StockData
Filana Therapeutics, Inc. logo

Filana Therapeutics, Inc. (FLNA) stock

FLNANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/30
$0.64+0.08 (+14.52%)

Close on Nov 20, 2026Market cap $30.98MP/E –Yield –

Filana Therapeutics r&d expenses

Research and development expenses are spending on new products and technology.

Filana Therapeutics's R&D Expenses for the twelve months ending Jun 30, 2026 was $15.66M, down 72.5% year over year. For fiscal 2025 it was $26.59M, down 61.8% from the year before. Over ten years it grew 18.4% a year on average. The highest annual figure on record is $89.42M in fiscal 2023.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$26.59M-61.8%
FY2024Dec 31, 2024$69.64M-22.1%
FY2023Dec 31, 2023$89.42M+31.4%
FY2022Dec 31, 2022$68.03M+174.2%
FY2021Dec 31, 2021$24.81M+735.7%
FY2018Dec 31, 2018$2.97M-61.0%
FY2017Dec 31, 2017$7.62M-17.0%
FY2016Dec 31, 2016$9.18M+0.8%
FY2015Dec 31, 2015$9.10M+24.6%
FY2014Dec 31, 2014$7.31M+48.6%
FY2013Dec 31, 2013$4.92M-35.3%
FY2012Dec 31, 2012$7.61M-8.4%
FY2011Dec 31, 2011$8.30M-47.3%
FY2010Dec 31, 2010$15.75M-25.2%
FY2009Dec 31, 2009$21.06M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$3.30M-35.4%
Q1 FY2026Mar 31, 2026$4.54M-66.7%
Q4 FY2025Dec 31, 2025$3.85M-81.2%
Q3 FY2025Sep 30, 2025$3.96M-77.6%
Q2 FY2025Jun 30, 2025$5.12M-66.3%
Q1 FY2025Mar 31, 2025$13.67M-15.8%
Q4 FY2024Dec 31, 2024$20.53M+9.6%
Q3 FY2024Sep 30, 2024$17.68M-25.1%
Q2 FY2024Jun 30, 2024$15.20M-39.1%
Q1 FY2024Mar 31, 2024$16.23M-26.6%
Q4 FY2023Dec 31, 2023$18.73M+6.1%
Q3 FY2023Sep 30, 2023$23.60M+27.4%
Q2 FY2023Jun 30, 2023$24.97M+8006.8%
Q1 FY2023Mar 31, 2023$22.12M+3753.7%
Q4 FY2022Dec 31, 2022$17.65M+882500.0%
Q3 FY2022Sep 30, 2022$18.53M+1166.3%
Q2 FY2019Jun 30, 2019$308.00K-78.9%
Q1 FY2019Mar 31, 2019$574.00K-46.3%
Q4 FY2018Dec 31, 2018$2.00K-99.9%
Q3 FY2018Sep 30, 2018$1.46M-9.6%
Q2 FY2018Jun 30, 2018$1.46M-52.2%
Q1 FY2018Mar 31, 2018$1.07M-23.1%
Q4 FY2017Dec 31, 2017$1.54M+15.7%
Q3 FY2017Sep 30, 2017$1.62M-39.1%
Q2 FY2017Jun 30, 2017$3.06M–
Q1 FY2017Mar 31, 2017$1.39M–
Q4 FY2016Dec 31, 2016$1.34M–
Q3 FY2016Sep 30, 2016$2.66M–

More Filana Therapeutics figures

See a number that looks wrong?